Boiler, you have made some good posts. One that keeps my energy in this stock is precisely what you stated a little while ago.
Motiva - post stroke apathy- Phase2
NNZ2566- Intravenous- Brain Injuries-FDA Phase2
NNZ2566- Oral Administration- Brain Injuries-FDA Phase2
NNZ2566- Rett Syndrome-FDA Phase2
Perseis Cancer Research Program- monoclonal antibodies
How many bios have this type of arsenary up their sleeves? I'd say 1 in 500.
How come the SP is in the 2's? I think a true re-rate is due. There will be no rights issues, placements or other as we have CASH and hopefully a major that wants to put us into bed with them. I can feel it in my bones......
the bags are ready
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.65 |
Change
0.000(0.00%) |
Mkt cap ! $1.744B | |||
| Open | High | Low | Value | Volume |
| $13.70 | $13.76 | $13.56 | $3.689M | 270.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 37 | $13.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.66 | 1132 | 2 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |